NK Cell Therapy Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : April 2021 Pages : 166 Category: Pharma & Healthcare Report Code : HC0416988
NK Cell Therapy Market By Type (NK Cell Therapies, NK Cell Directed Antibodies), Application (Cancer, Acute Infectious Diseases, Immunoproliferative Disorders, Gastrointestinal Diseases, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The NK Cell Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Natural killer (NK) cell is a specialized immune effector cell type that plays a critical role in immune activation against abnormal cells. Natural killer (NK) cells are an essential part of tumor immunosurveillance, evidenced by higher cancer susceptibility and metastasis in association with diminished NK activity.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global NK Cell Therapy Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Kiadis Pharma
- Cytovia Therapeutics
- Nkarta, Inc.
- Fate Therapeutics
- EMERcell
- Glycostem,
- Phio Pharmaceuticals
- Innate Pharma, Inc.
- Gamida Cell
- Bellicum Phamaceuticals, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· NK Cell Therapy Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o NK Cell Therapies
o NK Cell Directed Antibodies
· NK Cell Therapy Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Cancer
o Acute Infectious Diseases
o Immunoproliferative Disorders
o Gastrointestinal Diseases
o Others
· NK Cell Therapy Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Kiadis Pharma
o Cytovia Therapeutics
o Nkarta, Inc.
o Fate Therapeutics
o EMERcell
o Glycostem,
o Phio Pharmaceuticals
o Innate Pharma, Inc.
o Gamida Cell
o Bellicum Phamaceuticals, Inc.
· NK Cell Therapy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America NK Cell Therapy Market, By Country
o U.S. NK Cell Therapy Market
o Canada NK Cell Therapy Market
o Mexico NK Cell Therapy Market
o Europe
§ Europe NK Cell Therapy Market, By Country
o UK NK Cell Therapy Market
o Germany NK Cell Therapy Market
o France NK Cell Therapy Market
o Russia NK Cell Therapy Market
o Italy NK Cell Therapy Market
o Rest of Europe NK Cell Therapy Market
o Asia-Pacific
§ Asia-Pacific NK Cell Therapy Market, By Country
o China NK Cell Therapy Market
o Japan NK Cell Therapy Market
o South Korea NK Cell Therapy Market
o India NK Cell Therapy Market
o Southeast Asia NK Cell Therapy Market
o Rest of Asia-Pacific NK Cell Therapy Market
o South America
§ South America NK Cell Therapy Market
o Brazil NK Cell Therapy Market
o Argentina NK Cell Therapy Market
o Columbia NK Cell Therapy Market
o Rest of South America NK Cell Therapy Market
o Middle East and Africa
§ Middle East and Africa NK Cell Therapy Market
o Saudi Arabia NK Cell Therapy Market
o UAE NK Cell Therapy Market
o Egypt NK Cell Therapy Market
o Nigeria NK Cell Therapy Market
o South Africa NK Cell Therapy Market
o Turkey NK Cell Therapy Market
o Rest of MEA NK Cell Therapy Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. NK Cell Therapy Market, By Type
5.1. Introduction
5.2. Global NK Cell Therapy Revenue and Market Share by Type (2017-2021)
5.2.1. Global NK Cell Therapy Revenue and Revenue Share by Type (2017-2021)
5.3. NK Cell Therapies
5.3.1. Global NK Cell Therapies Revenue and Growth Rate (2017-2021)
5.4. NK Cell Directed Antibodies
5.4.1. Global NK Cell Directed Antibodies Revenue and Growth Rate (2017-2021)
6. NK Cell Therapy Market, By Applications
6.1. Introduction
6.2. Global NK Cell Therapy Revenue and Market Share by Applications (2017-2021)
6.2.1. Global NK Cell Therapy Revenue and Revenue Share by Applications (2017-2021)
6.3. Cancer
6.3.1. Global Cancer Revenue and Growth Rate (2017-2021)
6.4. Acute Infectious Diseases
6.4.1. Global Acute Infectious Diseases Revenue and Growth Rate (2017-2021)
6.5. Immunoproliferative Disorders
6.5.1. Global Immunoproliferative Disorders Revenue and Growth Rate (2017-2021)
6.6. Gastrointestinal Diseases
6.6.1. Global Gastrointestinal Diseases Revenue and Growth Rate (2017-2021)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2021)
7. NK Cell Therapy Market, By Region
7.1. Introduction
7.2. Global NK Cell Therapy Revenue and Market Share by Regions
7.2.1. Global NK Cell Therapy Revenue by Regions (2017-2021)
7.3. North America NK Cell Therapy by Countries
7.3.1. North America NK Cell Therapy Revenue and Growth Rate (2017-2021)
7.3.2. North America NK Cell Therapy Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe NK Cell Therapy by Countries
7.4.1. Europe NK Cell Therapy Revenue and Growth Rate (2017-2021)
7.4.2. Europe NK Cell Therapy Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific NK Cell Therapy by Countries
7.5.1. Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific NK Cell Therapy Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America NK Cell Therapy by Countries
7.6.1. South America NK Cell Therapy Revenue and Growth Rate (2017-2021)
7.6.2. South America NK Cell Therapy Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa NK Cell Therapy by Countries
7.7.1. Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa NK Cell Therapy Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Kiadis Pharma
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Cytovia Therapeutics
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Nkarta, Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. EMERcell
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Fate Therapeutics
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Glycostem,
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Phio Pharmaceuticals
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Innate Pharma, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Gamida Cell
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Bellicum Phamaceuticals, Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. NK Cell Therapy Market Forecast (2022-2027)
9.1. Global NK Cell Therapy Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. NK Cell Therapy Market Forecast by Regions (2022-2027)
9.2.1. North America NK Cell Therapy Market Forecast (2022-2027)
9.2.1.1. United States NK Cell Therapy Market Forecast (2022-2027)
9.2.1.2. Canada NK Cell Therapy Market Forecast (2022-2027)
9.2.1.3. Mexico NK Cell Therapy Market Forecast (2022-2027)
9.2.2. Europe NK Cell Therapy Market Forecast (2022-2027)
9.2.2.1. Germany NK Cell Therapy Market Forecast (2022-2027)
9.2.2.2. France NK Cell Therapy Market Forecast (2022-2027)
9.2.2.3. UK NK Cell Therapy Market Forecast (2022-2027)
9.2.2.4. Russia NK Cell Therapy Market Forecast (2022-2027)
9.2.2.5. Italy NK Cell Therapy Market Forecast (2022-2027)
9.2.2.6. Rest of Europe NK Cell Therapy Market Forecast (2022-2027)
9.2.3. Asia-Pacific NK Cell Therapy Market Forecast (2022-2027)
9.2.3.1. China NK Cell Therapy Market Forecast (2022-2027)
9.2.3.2. Japan NK Cell Therapy Market Forecast (2022-2027)
9.2.3.3. Korea NK Cell Therapy Market Forecast (2022-2027)
9.2.3.4. India NK Cell Therapy Market Forecast (2022-2027)
9.2.3.5. Southeast Asia NK Cell Therapy Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific NK Cell Therapy Market Forecast (2022-2027)
9.2.4. South America NK Cell Therapy Market Forecast (2022-2027)
9.2.4.1. Brazil NK Cell Therapy Market Forecast (2022-2027)
9.2.4.2. Argentina NK Cell Therapy Market Forecast (2022-2027)
9.2.4.3. Columbia NK Cell Therapy Market Forecast (2022-2027)
9.2.4.4. Rest of South America NK Cell Therapy Market Forecast (2022-2027)
9.2.5. Middle East and Africa NK Cell Therapy Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia NK Cell Therapy Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates NK Cell Therapy Market Forecast (2022-2027)
9.2.5.3. Egypt NK Cell Therapy Market Forecast (2022-2027)
9.2.5.4. Nigeria NK Cell Therapy Market Forecast (2022-2027)
9.2.5.5. South Africa NK Cell Therapy Market Forecast (2022-2027)
9.2.5.6. Turkey NK Cell Therapy Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa NK Cell Therapy Market Forecast (2022-2027)
9.3. NK Cell Therapy Market Forecast by Type (2022-2027)
9.3.1. NK Cell Therapy Forecast by Type (2022-2027)
9.3.2. NK Cell Therapy Market Share Forecast by Type (2022-2027)
9.4. NK Cell Therapy Market Forecast by Applications (2022-2027)
9.4.1. NK Cell Therapy Forecast by Applications (2022-2027)
9.4.2. NK Cell Therapy Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure France NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure China NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure India NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa NK Cell Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Table Global NK Cell Therapy Revenue and Revenue Share by Type (2017-2019)
Figure Global NK Cell Therapies Revenue and Growth Rate (2017-2019)
Figure Global NK Cell Directed Antibodies Revenue and Growth Rate (2017-2019)
Table Global NK Cell Therapy Revenue and Revenue Share by Applications (2017-2019)
Figure Global Cancer Revenue and Growth Rate (2017-2019)
Figure Global Acute Infectious Diseases Revenue and Growth Rate (2017-2019)
Figure Global Immunoproliferative Disorders Revenue and Growth Rate (2017-2019)
Figure Global Gastrointestinal Diseases Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global NK Cell Therapy Revenue by Regions (2017-2019)
Figure North America NK Cell Therapy Growth Rate (2017-2019)
Figure North America NK Cell Therapy Revenue and Growth Rate (2017-2019)
Figure North America NK Cell Therapy by Countries (2017-2019)
Figure North America NK Cell Therapy Revenue (Million USD) by Countries (2017-2019)
Figure United States NK Cell Therapy Growth Rate (2017-2019)
Figure United States NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada NK Cell Therapy Growth Rate (2017-2019)
Figure Canada NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico NK Cell Therapy Growth Rate (2017-2019)
Figure Mexico NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe NK Cell Therapy Growth Rate (2017-2019)
Figure Europe NK Cell Therapy Revenue and Growth Rate (2017-2019)
Figure Europe NK Cell Therapy by Countries (2017-2019)
Figure Europe NK Cell Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Germany NK Cell Therapy Growth Rate (2017-2019)
Figure Germany NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France NK Cell Therapy Growth Rate (2017-2019)
Figure France NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK NK Cell Therapy Growth Rate (2017-2019)
Figure UK NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia NK Cell Therapy Growth Rate (2017-2019)
Figure Russia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy NK Cell Therapy Growth Rate (2017-2019)
Figure Italy NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe NK Cell Therapy Growth Rate (2017-2019)
Figure Rest of Europe NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific NK Cell Therapy Growth Rate (2017-2019)
Figure Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific NK Cell Therapy by Countries (2017-2019)
Figure Asia-Pacific NK Cell Therapy Revenue (Million USD) by Countries (2017-2019)
Figure China NK Cell Therapy Growth Rate (2017-2019)
Figure China NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan NK Cell Therapy Growth Rate (2017-2019)
Figure Japan NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea NK Cell Therapy Growth Rate (2017-2019)
Figure Korea NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India NK Cell Therapy Growth Rate (2017-2019)
Figure India NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia NK Cell Therapy Growth Rate (2017-2019)
Figure Southeast Asia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific NK Cell Therapy Growth Rate (2017-2019)
Figure Rest of Asia-Pacific NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America NK Cell Therapy Growth Rate (2017-2019)
Figure South America NK Cell Therapy Revenue and Growth Rate (2017-2019)
Figure South America NK Cell Therapy by Countries (2017-2019)
Figure South America NK Cell Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Brazil NK Cell Therapy Growth Rate (2017-2019)
Figure Brazil NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina NK Cell Therapy Growth Rate (2017-2019)
Figure Argentina NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia NK Cell Therapy Growth Rate (2017-2019)
Figure Columbia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America NK Cell Therapy Growth Rate (2017-2019)
Figure Rest of South America NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa NK Cell Therapy Growth Rate (2017-2019)
Figure Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa NK Cell Therapy by Countries (2017-2019)
Figure Middle East and Africa NK Cell Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia NK Cell Therapy Growth Rate (2017-2019)
Figure Saudi Arabia NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates NK Cell Therapy Growth Rate (2017-2019)
Figure United Arab Emirates NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt NK Cell Therapy Growth Rate (2017-2019)
Figure Egypt NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria NK Cell Therapy Growth Rate (2017-2019)
Figure Nigeria NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa NK Cell Therapy Growth Rate (2017-2019)
Figure South Africa NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey NK Cell Therapy Growth Rate (2017-2019)
Figure Turkey NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa NK Cell Therapy Growth Rate (2017-2019)
Figure Rest of Middle East and Africa NK Cell Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Table Kiadis Pharma NK Cell Therapy Financial Overview
Table Cytovia Therapeutics NK Cell Therapy Financial Overview
Table Nkarta, Inc. NK Cell Therapy Financial Overview
Table EMERcell NK Cell Therapy Financial Overview
Table Fate Therapeutics NK Cell Therapy Financial Overview
Table Glycostem, NK Cell Therapy Financial Overview
Table Phio Pharmaceuticals NK Cell Therapy Financial Overview
Table Innate Pharma, Inc. NK Cell Therapy Financial Overview
Table Gamida Cell NK Cell Therapy Financial Overview
Table Bellicum Phamaceuticals, Inc. NK Cell Therapy Financial Overview
Figure Global NK Cell Therapy Revenue (Millions USD) and Growth Rate (2019-2027)
Table NK Cell Therapy Market Forecast by Regions (2019-2027)
Figure North America NK Cell Therapy Market Forecast (2019-2027)
Figure United States NK Cell Therapy Market Forecast (2019-2027)
Figure Canada NK Cell Therapy Market Forecast (2019-2027)
Figure Mexico NK Cell Therapy Market Forecast (2019-2027)
Figure Europe NK Cell Therapy Market Forecast (2019-2027)
Figure Germany NK Cell Therapy Market Forecast (2019-2027)
Figure France NK Cell Therapy Market Forecast (2019-2027)
Figure UK NK Cell Therapy Market Forecast (2019-2027)
Figure Russia NK Cell Therapy Market Forecast (2019-2027)
Figure Italy NK Cell Therapy Market Forecast (2019-2027)
Figure Rest of Europe NK Cell Therapy Market Forecast (2019-2027)
Figure Asia-Pacific NK Cell Therapy Market Forecast (2019-2027)
Figure China NK Cell Therapy Market Forecast (2019-2027)
Figure Japan NK Cell Therapy Market Forecast (2019-2027)
Figure Korea NK Cell Therapy Market Forecast (2019-2027)
Figure India NK Cell Therapy Market Forecast (2019-2027)
Figure Southeast Asia NK Cell Therapy Market Forecast (2019-2027)
Figure Rest of Asia-Pacific NK Cell Therapy Market Forecast (2019-2027)
Figure South America NK Cell Therapy Market Forecast (2019-2027)
Figure Brazil NK Cell Therapy Market Forecast (2019-2027)
Figure Argentina NK Cell Therapy Market Forecast (2019-2027)
Figure Columbia NK Cell Therapy Market Forecast (2019-2027)
Figure Rest of South America NK Cell Therapy Market Forecast (2019-2027)
Figure Middle East and Africa NK Cell Therapy Market Forecast (2019-2027)
Figure Saudi Arabia NK Cell Therapy Market Forecast (2019-2027)
Figure United Arab Emirates NK Cell Therapy Market Forecast (2019-2027)
Figure Egypt NK Cell Therapy Market Forecast (2019-2027)
Figure Nigeria NK Cell Therapy Market Forecast (2019-2027)
Figure South Africa NK Cell Therapy Market Forecast (2019-2027)
Figure Turkey NK Cell Therapy Market Forecast (2019-2027)
Figure Rest of Middle East and Africa NK Cell Therapy Market Forecast (2019-2027)
Figure Global NK Cell Therapy Forecast by Type (2019-2027)
Figure Global NK Cell Therapy Market Share Forecast by Type (2019-2027)
Figure Global NK Cell Therapy Forecast by Type (2019-2027)
Figure Global NK Cell Therapy Forecast by Applications (2019-2027)
Figure Global NK Cell Therapy Market Share Forecast by Applications (2019-2027)
Figure Global NK Cell Therapy Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|